Multi-Type Interdependent Feature Analysis Based on Hybrid Neural Networks for Computer-Aided Diagnosis of Epidermal Growth Factor Receptor Mutations

The mutation status of the epidermal growth factor receptor (EGFR) is an important clinical reference indicator for lung cancer diagnosis and treatment. However, the extraction of effective discriminative features for non-invasive computer-aided EGFR mutation prediction still poses a big challenge. In this paper, multiple types of features are designed and analyzed to address this problem. These features include clinical features based on prior medical knowledge and quantitative image features extracted by convolutional neural networks (CNN). A long short-term memory (LSTM) network is also introduced to exploit the dependency between these feature types and then fuse them. In particular, a CNN is constructed to extract quantitative features of computed-tomography (CT) images. Furthermore, a LSTM is utilized to analyze the dependency between these clinical and CT image features and generate a new feature representation for computer-aided diagnosis. For samples from the same category, the proposed method deal with feature representation variabilities arising from interdependencies in multi-type features and patient specificity. The multiple feature types of the collected clinical data are used to assess the proposed approach and other relevant algorithms. Our results demonstrate that the multi-type dependency-based feature representation shows superior performance (Accuracy = 75%, AUC = 0.78) compared to single-type feature representations. The proposed method is reliable to apply for diagnosing of the EGFR mutation status.

[1]  Renato Martins,et al.  Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.

[2]  Alona Muzikansky,et al.  First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Chun-Ming Tsai,et al.  Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Geraint Rees,et al.  Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.

[5]  D.M. Mount,et al.  An Efficient k-Means Clustering Algorithm: Analysis and Implementation , 2002, IEEE Trans. Pattern Anal. Mach. Intell..

[6]  Masahiro Endo,et al.  The Impact of Clinical Outcomes According to EGFR Mutation Status in Patients with Locally Advanced Lung Adenocarcinoma Who Recieved Concurrent Chemoradiotherapy , 2014, American journal of clinical oncology.

[7]  Ronald M. Summers,et al.  Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning , 2016, IEEE Transactions on Medical Imaging.

[8]  X. Chen,et al.  Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations , 2015, European Radiology.

[9]  Liang Chen,et al.  Attention-Gated Networks for Improving Ultrasound Scan Plane Detection , 2018, MICCAI 2018.

[10]  Tianhong Li,et al.  Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Xiuying Wang,et al.  Learning Deep Spatial Lung Features by 3D Convolutional Neural Network for Early Cancer Detection , 2017, 2017 International Conference on Digital Image Computing: Techniques and Applications (DICTA).

[12]  Xiwen Sun,et al.  Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma. , 2019, European journal of radiology.

[13]  Jun Ma,et al.  Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. , 2011, The Lancet. Oncology.

[14]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[15]  John Quackenbush,et al.  Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.

[16]  Kilian Q. Weinberger,et al.  Densely Connected Convolutional Networks , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[17]  Raunak Dey,et al.  Diagnostic classification of lung nodules using 3D neural networks , 2018, 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018).

[18]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[19]  David Cella,et al.  Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. , 2003, JAMA.

[20]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[21]  Raghuram Srinivasan,et al.  Convolutional neural networks for lung cancer screening in computed tomography (CT) scans , 2016, 2016 2nd International Conference on Contemporary Computing and Informatics (IC3I).

[22]  H. Hricak,et al.  Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. , 2013, Radiology.

[23]  Fabio A. González,et al.  Gated Multimodal Units for Information Fusion , 2017, ICLR.

[24]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[25]  William Pao,et al.  Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma , 2011, European Respiratory Journal.

[26]  Masaki Hara,et al.  Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  Rufaidah Rushdi,et al.  Common Fallacies of Probability in Medical Context: A Simple Mathematical Exposition , 2018 .

[28]  Ying Liu,et al.  CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma. , 2016, Radiology.

[29]  Haibo Zhang,et al.  Interstitial lung disease classification using improved DenseNet , 2018, Multimedia Tools and Applications.

[30]  H. Aerts Semantics Features : Phenotype Quantification by a Radiologist ’ s Expert Eye , 2016 .

[31]  Junzhou Huang,et al.  Efficient Lung Cancer Cell Detection with Deep Convolution Neural Network , 2015, Patch-MI@MICCAI.

[32]  Wenqing Sun,et al.  Computer aided lung cancer diagnosis with deep learning algorithms , 2016, SPIE Medical Imaging.

[33]  Jürgen Schmidhuber,et al.  Long Short-Term Memory , 1997, Neural Computation.

[34]  Nicolas Girard,et al.  Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma , 2012, European Respiratory Journal.

[35]  C F Loughran,et al.  Seeding of tumour cells following breast biopsy: a literature review. , 2011, The British journal of radiology.

[36]  Y. Liu,et al.  Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas. , 2016, Clinical lung cancer.